Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 1
2012 1
2013 3
2014 5
2015 4
2016 2
2017 6
2018 1
2019 7
2020 4
2021 2
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Enavogliflozin versus Dapagliflozin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus: A 24-Week, Double-Blind, Randomized Trial.
Han KA, Kim YH, Kim DM, Lee BW, Chon S, Sohn TS, Jeong IK, Hong EG, Son JW, Nah JJ, Song HR, Cho SI, Cho SA, Yoon KH. Han KA, et al. Among authors: kim dm. Diabetes Metab J. 2023 Nov;47(6):796-807. doi: 10.4093/dmj.2022.0315. Epub 2023 Feb 9. Diabetes Metab J. 2023. PMID: 36756676 Free PMC article. Clinical Trial.
Anagliptin twice-daily regimen improves glycaemic variability in subjects with type 2 diabetes: A double-blind, randomized controlled trial.
Lee YH, Kim DM, Yu JM, Choi KM, Kim SG, Park KS, Son HS, Chung CH, Ahn KJ, Lee SH, Song KH, Kwon SK, Park HK, Won KC, Jang HC; ACACIA Study Group. Lee YH, et al. Among authors: kim dm. Diabetes Obes Metab. 2023 May;25(5):1174-1185. doi: 10.1111/dom.14959. Epub 2023 Jan 10. Diabetes Obes Metab. 2023. PMID: 36564983 Clinical Trial.
Diabetes and COVID-19: IDF perspective in the Western Pacific region.
Hwang Y, Khasag A, Jia W, Jenkins A, Huang CN, Yabe D, Kim DM, Kadowaki T, Lee MK. Hwang Y, et al. Among authors: kim dm. Diabetes Res Clin Pract. 2020 Aug;166:108278. doi: 10.1016/j.diabres.2020.108278. Epub 2020 Jun 25. Diabetes Res Clin Pract. 2020. PMID: 32592842 Free PMC article.
Efficacy and safety of lobeglitazone versus sitagliptin as an add-on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeks.
Kim SG, Kim KJ, Yoon KH, Chun SW, Park KS, Choi KM, Lim S, Mok JO, Lee HW, Seo JA, Cha BS, Kim MK, Shon HS, Choi DS, Kim DM. Kim SG, et al. Among authors: kim dm. Diabetes Obes Metab. 2020 Oct;22(10):1869-1873. doi: 10.1111/dom.14085. Epub 2020 Jun 18. Diabetes Obes Metab. 2020. PMID: 32406573 Clinical Trial.
38 results